13F HOLDINGS REPORT
Cormorant Asset Management, LP
Quarter ended Q3 2023 · Filed August 14, 2023 · Accession 0001583977-23-000003
Total Value
$1.79B
Positions
64
Other Managers
1
Confidential Omitted
No
Holdings (64)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 8,142,100 | $415.2M | 23.26% |
| 2 | AMBRX BIOPHARMA INC | 02290A102 | 9,616,155 | $158.3M | 8.87% |
| 3 | APELLIS PHARMACEUTICALS INC | APLS | 1,310,000 | $119.3M | 6.69% |
| 4 | BIOMEA FUSION INC | BMEA | 3,570,872 | $78.4M | 4.39% |
| 5 | BRIDGEBIO PHARMA INC | BBIO | 4,169,179 | $71.7M | 4.02% |
| 6 | ARCELLX INC | ACLX | 2,000,000 | $63.2M | 3.54% |
| 7 | IMMUNEERING CORP | IMRX | 4,204,364 | $42.6M | 2.39% |
| 8 | CYMABAY THERAPEUTICS INC | 23257D103 | 3,800,000 | $41.6M | 2.33% |
| 9 | PROTAGONIST THERAPEUTICS INC | PTGX | 1,500,000 | $41.4M | 2.32% |
| 10 | ENLIVEN THERAPEUTICS INC | ELVN | 1,936,133 | $39.5M | 2.21% |
| 11 | VAXCYTE INC | PCVX | 665,000 | $33.2M | 1.86% |
| 12 | DESIGN THERAPEUTICS INC | DSGN | 5,150,000 | $32.4M | 1.82% |
| 13 | ZENTALIS PHARMACEUTICALS INC | ZNTL | 1,095,000 | $30.9M | 1.73% |
| 14 | ERASCA INC | ERAS | 10,813,246 | $29.8M | 1.67% |
| 15 | AVIDITY BIOSCIENCES INC | 05370A108 | 2,612,115 | $29.0M | 1.62% |
| 16 | CABALETTA BIO INC | CABA | 2,221,739 | $28.7M | 1.61% |
| 17 | EYEPOINT PHARMACEUTICALS INC | EYPT | 3,200,000 | $27.8M | 1.56% |
| 18 | OLEMA PHARMACEUTICALS INC | OLMA | 3,082,000 | $27.8M | 1.56% |
| 19 | AEROVATE THERAPEUTICS INC | 008064107 | 1,561,696 | $26.8M | 1.50% |
| 20 | TARSUS PHARMACEUTICALS INC | TARS | 1,421,422 | $25.7M | 1.44% |
| 21 | 89BIO INC | 282559103 | 1,350,000 | $25.6M | 1.43% |
| 22 | AXSOME THERAPEUTICS INC | AXSM | 340,000 | $24.4M | 1.37% |
| 23 | STRUCTURE THERAPEUTICS INC | GPCR | 576,373 | $24.0M | 1.34% |
| 24 | EDGEWISE THERAPEUTICS INC | EWTX | 2,946,887 | $22.8M | 1.28% |
| 25 | VIRIDIAN THERAPEUTICS INC | VRDN | 850,000 | $20.2M | 1.13% |
| 26 | KARUNA THERAPEUTICS INC | 48576A100 | 80,000 | $17.3M | 0.97% |
| 27 | LONGBOARD PHARMACEUTICALS IN | 54300N103 | 2,353,141 | $17.3M | 0.97% |
| 28 | ROCKET PHARMACEUTICALS INC | RCKTW | 868,550 | $17.3M | 0.97% |
| 29 | AXONICS INC | 05465P101 | 322,240 | $16.3M | 0.91% |
| 30 | SAREPTA THERAPEUTICS INC | SRPT | 130,000 | $14.9M | 0.83% |
| 31 | PHARVARIS N V | PHVS | 973,614 | $14.7M | 0.83% |
| 32 | IDEAYA BIOSCIENCES INC | IDYA | 600,000 | $14.1M | 0.79% |
| 33 | BRIDGEBIO PHARMA INC | BBIO | 810,800 | $13.9M | 0.78% |
| 34 | COGENT BIOSCIENCES INC | COGT | 1,000,000 | $11.8M | 0.66% |
| 35 | IVERIC BIO INC | 46583P102 | 300,000 | $11.8M | 0.66% |
| 36 | STOKE THERAPEUTICS INC | STOK | 1,087,807 | $11.6M | 0.65% |
| 37 | PRAXIS PRECISION MEDICINES I | PRAX | 9,500,000 | $10.9M | 0.61% |
| 38 | IMMUNOVANT INC | IMVT | 550,000 | $10.4M | 0.58% |
| 39 | DISC MEDICINE INC | IRON | 225,000 | $10.0M | 0.56% |
| 40 | RHYTHM PHARMACEUTICALS INC | RYTM | 600,000 | $9.9M | 0.55% |
| 41 | LIANBIO | LIANY | 4,250,000 | $9.7M | 0.54% |
| 42 | MORPHIC HLDG INC | 61775R105 | 150,000 | $8.6M | 0.48% |
| 43 | ASTRIA THERAPEUTICS INC | 04635X102 | 1,000,000 | $8.3M | 0.47% |
| 44 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | 800,000 | $7.6M | 0.43% |
| 45 | GH RESEARCH PLC | GHRS | 593,043 | $7.0M | 0.39% |
| 46 | VERVE THERAPEUTICS INC | 92539P101 | 350,000 | $6.6M | 0.37% |
| 47 | RAPT THERAPEUTICS INC | 75382E109 | 325,000 | $6.1M | 0.34% |
| 48 | VIGIL NEUROSCIENCE INC | 92673K108 | 616,786 | $5.8M | 0.32% |
| 49 | ATEA PHARMACEUTICALS INC | AVIR | 1,547,181 | $5.8M | 0.32% |
| 50 | AKERO THERAPEUTICS INC | 00973Y108 | 115,000 | $5.4M | 0.30% |
| 51 | ALX ONCOLOGY HLDGS INC | ALXO | 612,079 | $4.6M | 0.26% |
| 52 | APELLIS PHARMACEUTICALS INC | APLS | 39,000 | $3.6M | 0.20% |
| 53 | BIOATLA INC | BCAB | 1,181,115 | $3.5M | 0.20% |
| 54 | CENTESSA PHARMACEUTICALS PLC | CNTA | 561,600 | $3.5M | 0.19% |
| 55 | LEAP THERAPEUTICS INC | CYPH | 1,073,046 | $3.4M | 0.19% |
| 56 | OCULAR THERAPEUTIX INC | OCUL | 645,000 | $3.3M | 0.19% |
| 57 | GREENLIGHT BIOSCIENCS HLDS P | 39536G105 | 9,188,659 | $2.7M | 0.15% |
| 58 | GALECTO INC | 36322Q107 | 1,020,238 | $2.6M | 0.14% |
| 59 | BIOHAVEN LTD | BHVN | 81,963 | $2.0M | 0.11% |
| 60 | AUTOLUS THERAPEUTICS PLC | AUTL | 392,167 | $933,357 | 0.05% |
| 61 | GRAPHITE BIO INC | 38870X104 | 199,547 | $518,822 | 0.03% |
| 62 | HARPOON THERAPEUTICS INC | 41358P106 | 540,600 | $383,826 | 0.02% |
| 63 | ATRECA INC | 04965G109 | 319,057 | $312,676 | 0.02% |
| 64 | ORCHARD THERAPEUTICS PLC | 68570P200 | 25,664 | $133,709 | 0.01% |